Matrix Metalloproteinase Expression After Human Cardioembolic Stroke
Top Cited Papers
- 1 August 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Stroke
- Vol. 32 (8), 1759-1766
- https://doi.org/10.1161/01.str.32.8.1759
Abstract
Background and Purpose— Uncontrolled expression of matrix metalloproteinases (MMPs) can result in tissue injury and inflammation. In animal models of cerebral ischemia, the expression of MMP-2 and ...Keywords
This publication has 17 references indexed in Scilit:
- Role for Matrix Metalloproteinase 9 after Focal Cerebral Ischemia: Effects of Gene Knockout and Enzyme Inhibition with BB-94Journal of Cerebral Blood Flow & Metabolism, 2000
- Early Appearance of Activated Matrix Metalloproteinase-9 after Focal Cerebral Ischemia in Mice: A Possible Role in Blood—Brain Barrier DysfunctionJournal of Cerebral Blood Flow & Metabolism, 1999
- Matrix MetalloproteinasesJournal of Biological Chemistry, 1999
- Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 1999
- Matrix Metalloproteinases in Cerebrovascular DiseaseJournal of Cerebral Blood Flow & Metabolism, 1998
- Regulation of Matrix Metalloproteinase Expression in Astrocytes, Microglia and NeuronsNeuroimmunomodulation, 1996
- Proteolytic Cascade Enzymes Increase in Focal Cerebral Ischemia in RatJournal of Cerebral Blood Flow & Metabolism, 1996
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Metalloproteinases and their inhibitors in matrix remodelingTrends in Genetics, 1990
- Collagenolytic metalloenzymes of the human neutrophilBiochemical Pharmacology, 1986